Back

CRISPR/Cas9-mediated Disruption of the Human R14del Mutation Suppresses Arrhythmias in a Novel Humanized Mouse Model of Arrhythmogenic Cardiomyopathy

28 August 2018 (11:00 - 11:15)
Organised by:
Congress Presentation Part of: Late Breaking Basic and Translational Science - Cardiac Biology Arrhythmias ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Nour Raad

Mount Sinai School of Medicine, New York (United States of America)

5 More presentations in this session

Presentation thumbnail
Impaired Excitation Contraction Coupling in Human Induced Pluripotent Stem Cell Derived Cardiac Myocytes from Arrhythmogenic Right Ventricular Cardiomyopathy Patients with a Plakophilin2 Mutation
Doctor K. Hammer (Regensburg, DE)
Presentation thumbnail
Arrhythmogenic Cardiomyopathy type 8 zebrafish models: opportunities for the identification of early pathogenetic events and new therapeutic targets
Associate Professor N. Tiso (Padova, IT)
Slides Video
Presentation thumbnail
BNP signal peptide protects the heart from ischemia-reperfusion injury
Professor C. Pemberton (Christchurch, NZ)
Slides Video
Presentation thumbnail
Mutations contributing to clonal hematopoiesis are associated with poor prognosis in chronic ischemic heart failure
Professor B. Assmus (Giessen, DE)
Presentation thumbnail
The SIRT1 activator resveratrol ameliorates dystrophic cardiomyopathy by promoting mitophagy.
Professor A. Kuno (Sapporo, JP)
Slides Video

Access the full session

Session thumbnail
Late Breaking Basic and Translational Science - Cardiac Biology

The Event

Event poster

ESC Congress 2018

28 August 2018 11:00 CET
You may be interested in
thumbnail
Congress Session
Risk stratification
thumbnail
Congress Session
Malignant arrhythmias
thumbnail
Congress Session
Novel arrhythmia treatments

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources